These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21926626)

  • 1. Clinical trials roundup in idiopathic inflammatory myopathies.
    Mann HF; Vencovský J
    Curr Opin Rheumatol; 2011 Nov; 23(6):605-11. PubMed ID: 21926626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic advances in myositis.
    Aggarwal R; Oddis CV
    Curr Opin Rheumatol; 2012 Nov; 24(6):635-41. PubMed ID: 22955021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modern Therapies for Idiopathic Inflammatory Myopathies (IIMs): Role of Biologics.
    Moghadam-Kia S; Oddis CV; Aggarwal R
    Clin Rev Allergy Immunol; 2017 Feb; 52(1):81-87. PubMed ID: 26767526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of idiopathic inflammatory myopathies.
    Amato AA; Griggs RC
    Curr Opin Neurol; 2003 Oct; 16(5):569-75. PubMed ID: 14501840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic strategy in inflammatory myopathies (polymyositis, dermatomyositis, overlap myositis, and immune-mediated necrotizing myopathy)].
    Tournadre A
    Rev Med Interne; 2014 Jul; 35(7):466-71. PubMed ID: 24144868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab therapy in patients with refractory dermatomyositis or polymyositis: differential effects in a real-life population.
    Unger L; Kampf S; Lüthke K; Aringer M
    Rheumatology (Oxford); 2014 Sep; 53(9):1630-8. PubMed ID: 24706995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the therapy of idiopathic inflammatory myopathies.
    Baer AN
    Curr Opin Rheumatol; 2006 May; 18(3):236-41. PubMed ID: 16582685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic options in autoimmune inflammatory myopathies (dermatomyositis, polymyositis, inclusion body myositis).
    Pongratz D
    J Neurol; 2006 Sep; 253 Suppl 5():V64-5. PubMed ID: 16998756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory myopathies: management of steroid resistance.
    Dalakas MC
    Curr Opin Neurol; 2011 Oct; 24(5):457-62. PubMed ID: 21799409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of rituximab treatment in patients with idiopathic inflammatory myopathies: A systematic review and meta-analysis.
    Zhen C; Hou Y; Zhao B; Ma X; Dai T; Yan C
    Front Immunol; 2022; 13():1051609. PubMed ID: 36578492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous dermatomyositis: an updated review of treatment options and internal associations.
    Femia AN; Vleugels RA; Callen JP
    Am J Clin Dermatol; 2013 Aug; 14(4):291-313. PubMed ID: 23754636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic therapy in the idiopathic inflammatory myopathies.
    Khoo T; Limaye V
    Rheumatol Int; 2020 Feb; 40(2):191-205. PubMed ID: 31680207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent clinical trials in idiopathic inflammatory myopathies.
    Leclair V; Lundberg IE
    Curr Opin Rheumatol; 2017 Nov; 29(6):652-659. PubMed ID: 28763333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of inflammatory muscle disease in adults.
    Tournadre A; Dubost JJ; Soubrier M
    Joint Bone Spine; 2010 Oct; 77(5):390-4. PubMed ID: 20627789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current treatment of the inflammatory myopathies.
    Dalakas MC
    Curr Opin Rheumatol; 1994 Nov; 6(6):595-601. PubMed ID: 7865379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of the inflammatory myopathies: update and practical recommendations.
    Hengstman GJ; van den Hoogen FH; van Engelen BG
    Expert Opin Pharmacother; 2009 May; 10(7):1183-90. PubMed ID: 19405792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy of polymyositis and dermatomyositis.
    Marie I; Mouthon L
    Autoimmun Rev; 2011 Nov; 11(1):6-13. PubMed ID: 21740984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biologic therapy in idiopathic inflammatory myopathy].
    Selva-O'Callaghan A; Ramos Casals M; Grau Junyent JM
    Med Clin (Barc); 2014 Sep; 143(6):275-80. PubMed ID: 24393419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab in the treatment of dermatomyositis and other inflammatory myopathies. A report of 4 cases and review of the literature.
    Rios Fernández R; Callejas Rubio JL; Sánchez Cano D; Sáez Moreno JA; Ortego Centeno N
    Clin Exp Rheumatol; 2009; 27(6):1009-16. PubMed ID: 20149324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biological therapy in idiopathic inflammatory myopathies].
    Bodoki L; Nagy-Vincze M; Griger Z; Péter A; András C; Dankó K
    Orv Hetil; 2014 Jan; 155(1):3-10. PubMed ID: 24379090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.